Covid-19 vaccination: COVAX in talks with govt to ensure speedy deliveries

SII is committed to supplying 200 million doses to the collaboration

After the Centre asked vaccine makers — Serum Institute of India (SII) and Bharat Biotech — to prioritise deliveries of the Covid-19 vaccine to meet domestic requirements, global public-private outfit Gavi criticised the move. In fact, COVAX, the World Health Organisation (WHO)-led Covid-19 vaccine collaboration, has initiated talks with the Indian government to ensure deliveries can happen quickly.
 
In a statement Gavi, which is also co-leading the COVAX facility said, “Delays in granting further export licenses for SII-produced vaccine doses are due to the increased demand of Covid-19 vaccines in India.”
 
It further added: “SII has pledged that,